23andMe

23andMe Receives FDA Clearance for Direct-to-Consumer Genetic Test on a Hereditary Colorectal Cancer Syndrome

January 22, 2019

This release is archived. Please refer to the title and date above. For media inquiries contact [email protected].

23andMe Receives FDA Clearance for Direct-to-Consumer Genetic Test on a Hereditary Colorectal Cancer Syndrome | 23andMe Media Center